MarketPeel
Insider Trading Intelligence
PK

Peter A. Kiener

CUE
DIRECTOR · CUE BIOPHARMA, INC. · CIK 0001328146
FILING MIX · LIFETIME63%/37%
BUYS
10
SELLS
6
TOTAL VALUE
$477.7K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
24,400
AVG SELL PX
$13.30
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Peter A. Kiener, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-10.20%+0.82%-11.03%-16.70%
14d3+66.67%-19.49%+0.18%-19.67%-25.25%
30d3+66.67%-20.00%+1.64%-21.64%-34.49%
60d3+66.67%-23.00%+1.89%-24.89%-41.09%
90d3+66.67%-35.72%-0.28%-35.44%-54.63%
180d3+100.00%-62.35%-4.75%-57.60%-64.62%
1y3+100.00%-66.56%+2.19%-68.75%-65.37%
2y3+100.00%-80.96%+15.17%-96.13%-85.87%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CUE · 24,400 shares · as of Jan 2, 2026
026,77653,55380,329107,105202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 10 buys / 6 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
24,40024,400Jan 2, 2026Jan 6, 2026View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
24,40024,400Jan 2, 2025Jan 3, 2025View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
24,40024,400Jan 2, 2024Jan 4, 2024View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
9,682$2.86$27.7K9,682Mar 23, 2023Mar 27, 2023View →
CUE
CUE BIOPHARMA, INC.
SALE
9,325$3.28$30.6K357Mar 23, 2023Mar 27, 2023View →
CUE
CUE BIOPHARMA, INC.
SALE
9,68296,062Mar 23, 2023Mar 27, 2023View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 3, 2023Jan 5, 2023View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 3, 2022Jan 5, 2022View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
1,361$2.86$3.9K1,361Nov 16, 2021Nov 17, 2021View →
CUE
CUE BIOPHARMA, INC.
SALE
1,361105,744Nov 16, 2021Nov 17, 2021View →
CUE
CUE BIOPHARMA, INC.
SALE
1,361$18.02$24.5K0Nov 16, 2021Nov 17, 2021View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
18,815$2.86$53.8K18,815Nov 15, 2021Nov 17, 2021View →
CUE
CUE BIOPHARMA, INC.
SALE
18,815107,105Nov 15, 2021Nov 17, 2021View →
CUE
CUE BIOPHARMA, INC.
SALE
18,815$17.92$337.2K0Nov 15, 2021Nov 17, 2021View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 4, 2021Jan 6, 2021View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
8,0008,000Jan 2, 2020Jan 6, 2020View →
Other insiders · CUE
Loading peer insiders…
About this filer
CIK 0001328146
ROLE
Director
PRIMARY
CUE
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001328146DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback